日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

[89Zr]-immuno-PET prediction of response to rituximab treatment in patients with therapy refractory interstitial pneumonitis: a phase 2 trial

[89Zr]免疫PET预测难治性间质性肺炎患者对利妥昔单抗治疗的反应:一项II期试验

Adams, H; van de Garde, E M W; Vugts, D J; Grutters, J C; Oyen, Wim J G; Keijsers, R G

Characterization of the PF-ILD phenotype in patients with advanced pulmonary sarcoidosis

晚期肺结节病患者PF-ILD表型的特征分析

Schimmelpennink, M C; Meek, D B; Vorselaars, A D M; Langezaal, L C M; van Moorsel, C H M; van der Vis, J J; Veltkamp, M; Grutters, J C

Potential interstitial lung abnormalities on chest X-rays prior to symptoms of idiopathic pulmonary fibrosis

特发性肺纤维化症状出现前胸部X光片上可能存在的间质性肺异常

Hoffman, T W; van Es, H W; Biesma, D H; Grutters, J C

Simultaneous testing of immunological sensitization to multiple antigens in sarcoidosis reveals an association with inorganic antigens specifically related to a fibrotic phenotype

同时检测结节病患者对多种抗原的免疫致敏情况,发现其与纤维化表型相关的无机抗原存在关联。

Beijer, E; Kraaijvanger, R; Roodenburg, C; Grutters, J C; Meek, B; Veltkamp, M

The usefulness of repeated CMR and FDG PET/CT in the diagnosis of patients with initial possible cardiac sarcoidosis

重复进行CMR和FDG PET/CT检查在诊断疑似心脏结节病患者中的应用价值

Mathijssen, H; Tjoeng, T W H; Keijsers, R G M; Bakker, A L M; Akdim, F; van Es, H W; van Beek, F T; Veltkamp, M V; Grutters, J C; Post, M C

Patient expectations, experiences and satisfaction with nintedanib and pirfenidone in idiopathic pulmonary fibrosis: a quantitative study

特发性肺纤维化患者对尼达尼布和吡非尼酮的期望、体验和满意度:一项定量研究

Moor, C C; Mostard, R L M; Grutters, J C; Bresser, P; Aerts, J G J V; Dirksen, C D; Kimman, M L; Wijsenbeek, M S

Safety of macitentan in sarcoidosis-associated pulmonary hypertension: a case-series

马西替坦治疗结节病相关肺动脉高压的安全性:病例系列研究

Mathijssen, H; Huitema, M P; Bakker, A L M; Mager, J J; Snijder, R J; Grutters, J C; Post, M C

Infliximab therapy balances regulatory T cells, tumour necrosis factor receptor 2 (TNFR2) expression and soluble TNFR2 in sarcoidosis

英夫利昔单抗疗法平衡结节病中的调节性T细胞、肿瘤坏死因子受体2 (TNFR2) 表达和可溶性TNFR2。

Verwoerd, A; Hijdra, D; Vorselaars, A D M; Crommelin, H A; van Moorsel, C H M; Grutters, J C; Claessen, A M E

TINF2 Gene Mutation in a Patient with Pulmonary Fibrosis

肺纤维化患者的 TINF2 基因突变

Hoffman, T W; van der Vis, J J; van Oosterhout, M F M; van Es, H W; van Kessel, D A; Grutters, J C; van Moorsel, C H M

A case highly suspicious of isolated cardiac sarcoidosis

高度疑似孤立性心脏结节病的病例

Huitema, M P; Swaans, M J; Grutters, J C; Post, M C